Home NDC 83831-144 Avopef
Product NDC 83831-144
11-digit product format 838310144
Labeler code 83831
Product ID 83831-144_3421b13e-3145-4ca9-9fdb-2c1ff2b14e51
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name etoposide
Dosage form INJECTION
Route INTRAVENOUS
Labeler AVYXA Pharma, LLC
Application NDA220200
Marketing category NDA
Marketing start 2026-04-01
Substance ETOPOSIDE
Active strength 100 mg/5mL
Pharmacologic classes Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N220200-001 AVOPEF ETOPOSIDE 100MG/5ML (20MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2026-02-13 N220200-002 AVOPEF ETOPOSIDE 500MG/25ML (20MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2026-06-24
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N220200-001 AVOPEF 100MG/5ML (20MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2026-02-13 84e616aacf4f…2026-09-14 22:38:34 2026-08 N220200-002 AVOPEF 500MG/25ML (20MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2026-06-24 84e616aacf4f…2026-08-18 06:07:40 2026-07 N220200-001 AVOPEF 100MG/5ML (20MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2026-02-13 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N220200-002 AVOPEF 500MG/25ML (20MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2026-06-24 caaa826d4ba7…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N220200-001 AVOPEF 100MG/5ML (20MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2026-02-13 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N220200-002 AVOPEF 500MG/25ML (20MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2026-06-24 a50c72e98297…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Avopef
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ETOPOSIDE 100 mg/5mL
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 83831-144-05 Avopef 5 mL in 1 VIAL INJECTION 5 7 83831-144-05 Avopef 1 in 1 CARTON INJECTION 1 7
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 83831-144-05 83831014405 1 VIAL in 1 CARTON (83831-144-05) / 5 mL in 1 VIAL 1 vial 2026-04-01 No No Current